Veeva Network for compiling physician master-data lists and related prescriber data has initial customers
Veeva (Pleasanton, CA), said to be the fastest-growing CRM vendor in life sciences, went public on the NY Stock Exchange on Oct. 16; initially priced at $20 per share, the company’s stock popped 87% in its first day, closing at $37.37, while generating $261 million for the company.
In the runup and now subsequent to its IPO, the company is shifting its identity from a CRM vendor riding the iPad wave to a “cloud services for life sciences” company, says newly promoted president, Matt Wallach. It has followed through on announcements made this spring to add services for organizing and storing drug-development and promotional material (in Veeva Vault), and a HIPPA-compliant email service for physicians and pharma reps, as well as Veeva Network for compiling master databases on physician identities, addresses and affiliations. “We’re transitioning from basic CRM sales software to becoming the industry’s preferred cloud services, software and data provider,” he says.
Veeva Network, which now has four bipharma companies in its early-adopter program, presents an especially intriguing potential. Wallach says that life sciences customers it has approached are uniformly enthusiastic about sharing their master data on physicians—a form of “crowdsourcing” in which the pooled results benefit all participants. In theory, as Veeva CRM clients input their routine sales call data into Veeva repositories, those data will quickly become an accurate, up-to-the-minute database of physician locations, contact information, licensure and email addresses, with professional affiliations also a strong possibility. Currently, a dozen or so vendors sell these master data lists to manufacturers; for Veeva customers, those data essentially become free. To this end, the company acquired one of these master-date vendors, AdvantageMS, earlier this year, and is building similar capabilities outside the US (the company currently has offices in nine countries.)
In practice, says Wallach, the basic master data will be shared, but each Veeva client will be able to create its own data-field extensions to store proprietary data on, for example, physician response to sales messaging. At some point—but not yet—Veeva Network will be available to non-CRM clients.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.